Wmp/26076/2021 Of M/S.pharmazell Vizag Private Limited v. Additional / Joint Deputy / Asst Commissioner Of Income Tax
High Court
07 Nov 2023 In favour of: Unclear
Forum / Bench
High Court · hc_cis_mas
Parties
Wmp/26076/2021 Of M/S.pharmazell Vizag Private Limited v. Additional / Joint Deputy / Asst Commissioner Of Income Tax
Date of order
07 Nov 2023
Assessment year(s)
—
Outcome
Other
Case summary
In Wmp/26076/2021 Of M/S.pharmazell Vizag Private Limited v. Additional / Joint Deputy / Asst Commissioner Of Income Tax, the High Court (2023) decided the matter.
Summary auto-generated from the order below — read the full judgment for the complete reasoning.
The order — as passed by the High Court
W.M.P. No.26076 of 2021
in
W.P. No.22468 of 2021
MOHAMMED SHAFFIQ, J.
The writ miscellaneous petition is filed
praying to amend the cause title and substitute the name as M/s.PharmaZell (India) Private Limited, (Company into which M/s.Pharmazell Vizag Private Ltd., was amalgamated) Plot No.B5 and B6, MEPZ, Tambaram, Chennai-600 045, Represented by its Chief Financial Officer Shri Karthik N in place of M/s.PharmaZell Vizag Pvt. Ltd. Plot No.115, Ramky Pharma City (India) Ltd., SEZ, Parwada Visakhapatnam 531 021, Andhra Pradesh.
2. Having been satisfied with the reasons stated in the affidavit filed in support of this petition, this petition is ordered as prayed for. The learned Senior Standing Counsel for the Respondents does not have any serious objection to the same.
3. Registry is directed to carry out necessary amendments in the cause title.
07.11.2023
mka
This page reproduces a public-domain court order (Section 52(1)(q)(iv), Copyright Act 1957). Explanations are EaseValue's original analysis. Always read the original order.
Disclaimer: General information only — not legal, tax or professional advice, and no advocate/CA–client relationship is created. AI-generated summaries may contain errors and must be verified against the original court order. EaseValue accepts no liability for reliance on this content. Not a solicitation.
Full disclaimer & Terms.